期刊文献+

马栗种子提取物治疗黄斑水肿的临床疗效观察 被引量:1

Clinical effect of the oral horse chestnut seed extract for treating macular edema
下载PDF
导出
摘要 目的:观察口服马栗种子提取物对黄斑水肿的临床疗效。方法:将黄斑水肿患者47例50眼随机分为2组,对照组采用常规促吸收疗法(口服维生素C,E和芦丁片),治疗组在常规治疗基础上加用马栗种子提取物口服,4wk为1疗程。结果:治疗组黄斑水肿吸收优于对照组,两组差异有显著意义(P<0.05),治疗组患者无1例不良反应。结论:马栗种子提取物对黄斑水肿疗效确切,无不良反应,可在临床上推广应用。 AIM:To observe the clinical efficacy of the oral horse chestnut seed extract for treating macular edema.METHODS:Forty-seven cases(50 eyes) of macular edema patients(fifty eyes) were randomly divided into 2 groups.The conventional therapy(oral vitamin C,E and rutin tablets) was used in control group.The treatment group was treated with oral horse chestnut seed extract and conventional therapy.RESULTS:After 4 weeks observation,the absorption of macular edema in treatment group was better than the control group,the difference was significant(P0.05),no adverse reactions was observed in treatment group.CONCLUSION:The horse chestnut seed extract is effective for macular edema with no adverse reactions.
出处 《国际眼科杂志》 CAS 2012年第1期151-152,共2页 International Eye Science
关键词 马栗种子提取物 黄斑水肿 the horse chestnut seed extract macular edema
  • 相关文献

参考文献4

  • 1赵堪兴,杨培增.眼科学.第7版.北京:人民卫生出版社.2008.75.
  • 2Li CM,Liu ZF,Gao YL,et al.Investigation of blood toxicity in association with aescin (the horse chestnut seed extract).Toxicol Lett 2006;164 S,S90,P2-47.
  • 3Kreysel HW,Nissen HP,Enghoffer E.A possible role of lysosomal enzymes in the pathogenesis of varicosis and the reduction in their serum activity by venostasin.Vasa 1983;12(4):377-382.
  • 4Mora A,Pay M,Ros JL,et al.Structure-activity relationships of polymethoxyflavones and other flavonoids as inhibitors of non-enzymic lipid peroxidation.Biochem Pharmacol 1990;40(4):793-797.

共引文献50

同被引文献31

  • 1耿爽,叶俊杰.曲安奈德在眼科的应用[J].国外医学(眼科学分册),2005,29(3):190-195. 被引量:28
  • 2何梅凤,李瑜,吴伟,王延东.葛根素和血栓通治疗视网膜静脉阻塞的成本-效果分析[J].中药材,2006,29(8):879-880. 被引量:2
  • 3许建华,刘哲丽,李若溪,孔伟,张薇.曲安奈德对缺氧条件下恒河猴脉络膜视网膜内皮细胞VEGF表达的影响[J].国际眼科杂志,2006,6(5):1053-1055. 被引量:9
  • 4傅仁宇.审视瑶涵[M].上海:上海人民出版社,1959.57.
  • 5李凤鸣.中华眼科学[M].第2版.北京:人民卫生出版社,2006:1436,1450—1451,1475.
  • 6Timmerman EA, Renardel VW, Henry JB.Axiallength as a risk factor to branch retinal vein occlusion[J]. Retina, 1997,17 (1) : 196.
  • 7Vinores SA, Youssri AL, Luna JD, et al. Up-regulation of vascular endothelial growth factor in ischemic and non-ischemichuman and experimental retinal disease[J]. HistolHistopathol, 1997,12 ( 1 ) :99- 109.
  • 8Mcallister IL, Douglas JP, Con stable I.l,et al. Laser-induced chori- oretinal venous anastomos is for nonischeanie central retinal vein occlusion[J]. Am J Ophthalmol, 1998,126 (3) : 219-229.
  • 9Mathias A,Christoph T, Ute W,et al. Treatment of branch retinal vein occlusion induced macular edema with bevacizumab[J]. Graefe's Arch Clin Exp Ophthalmo1,2009,247( 1 ) :27-33.
  • 10Osterloh MD, Charles S. Surgical decompression of branch retinal vein occlusion[J]. Arch Ophthalmol, 1988,106(10) : 1469-1471.

引证文献1

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部